SADDLE BROOK, N.J., Oct. 21, 2010 (GLOBE NEWSWIRE) -- Herborium Group, Inc., (Pink Sheets:HBRM) www.herborium.com, a Botanical Therapeutics™ company, today announced it has retained SmallCap Support Services, a Houston based investor, media, and public relations firm.
"I am pleased to engage SmallCap Support Services to handle our growing investor relations needs and increase our trade & popular press coverage," commented Dr. Agnes P. Olszewski, Herborium Group's president and chief executive officer. "SmallCap ensures all Company information released will be clear and accurately conveyed.
"Herborium develops and markets novel, clinically tested Botanical Therapeutics® (botanical medicines), a distinctly separate product classification compared to simple nutraceuticals. Our products' differential advantage rests in clinical testing of its safety and efficacy and drives product development opportunities by the use of U.S. Food & Drug Administration (2004) and European Medicines Agency guidelines.
"Therefore, we required an IR/PR firm with the capacity to develop a working knowledge of Herborium and our products' differential market advantages. After careful consideration, I am pleased to announce SmallCap is such a firm.
"As we finalize marketing plans, I expect further personnel will also be needed to support our new product exposure initiatives, in particular, Herborium's new 2011 U.S. marketing campaign to aggressively promote its flagship product, AcnEase®."
AcnEase is a proprietary, botanical therapeutic product taken orally that prevents acne from forming in both females and males of all ages. Furthermore, AcnEase has been proven safe and effective in the treatment of both acne and rosacea through rigorous clinical testing (www.acnease.com).
"Roche's Accutane® was the leading prescriptive oral acne medication, until being removed from the market due to serious side-effects. The withdrawal of Accutane has presented Herborium with an enormous opportunity to capture market share with AcnEase -- the only all-natural, safe, and effective oral acne medicine."
"In conclusion, I look forward to soon sharing updates on AcnEase as well as our international sales," Olszewski concluded.
About SmallCap Support Services
SmallCap Support Services is a Houston-based boutique investor relations firm offering a full-range of services to emerging public companies primarily in the Technology, Oil & Gas, Telecom, Medicine, Entertainment, and Defense & Aerospace sectors. SmallCap Support Services works with both development stage and growth stage public companies delivering a full spectrum of affordable investor, public and media relations services. The firm takes on only a small number of honest, hardworking, and innovative clients, and then focuses passionately on their investor relations goals with professionalism, honesty, and integrity of method. For more information, please visit www.smallcapss.com.
About Herborium Group, Inc.
Herborium Group, Inc., a Botanical Therapeutics® company, focuses on developing, licensing, and marketing proprietary, botanical based medicinal products to consumers and healthcare professionals. The Company business model focuses on emerging market opportunities spearheaded by the growth of a new market sector located between high-cost, high-risk, ethical pharmaceuticals and commoditized classic nutraceuticals (supplements). The Company uses clinical validation and a proactive regulatory strategy based on the FDA Guidance for Industry: Botanical Drug Products (FDA Guidance 2004) to establish and maintain a differential advantage. For more information, please visit www.herborium.com and www.acnease.com.
One of our most important responsibilities is to communicate with shareholders in an open and direct manner. Comments are based on current management expectations, and are considered "forward-looking statements," generally preceded by words such as "plans," "expects," "believes," "anticipates," or "intends." We cannot promise future returns. Our statements reflect our best judgment at the time they are issued, and we disclaim any obligation to update or alter forward-looking statements as the result of new information or future events. The Company urges investors to review the risks and uncertainties contained within its filings with the OTC Markets and/or Securities and Exchange Commission.